Skip to main content
Department of Pharmaceutics

Research

Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems

 

 

# Title Research Year
91 Spleen Selective Enhancement of Transfection Activities of Plasmid DNA Driven by Octaarginine and An Ionizable Lipid and Its Implications for Cancer Immunization
2019
92 A Multifunctional Co-delivery Liposome for Targeted Chemotherapy and Gene Therapy for Hepatocellular Carcinoma 2019
93 Solubilization and Enhancement of Ex Vivo Vaginal Delivery of Progesterone Using Solid Dispersions, Inclusion Complexes and Micellar Solubilization 2018
94 Enhancing Docetaxel Delivery to Multidrug-Resistant Cancer Cells with Albumin-Coated Nanocrystals 2018
95 High Payload Nanostructured Lipid Carriers Fabricated with Alendronate/Polyethyleneimine Ion Complexes 2018
96 Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer : Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model 2018
97 Solubilization and Enhancement of Ex Vivo Vaginal Delivery of Progesterone Using Solid Dispersions, Inclusion Complexes and Micellar Solubilization 2018
98 Lipid-Coated Superparamagnetic Nanoparticles for Thermoresponsive Cancer Treatment 2018
99 High Payload Nanostructured Lipid Carriers Fabricated with Alendronate/Polyethyleneimine Ion Complexes 2018
100 ROLE OF SELF-EMULSIFYING DRUG DELIVERY SYSTEMS IN ENHANCING THE ORAL BIOAVAILABILITY OF BCS CLASS II DRUGS 2018